Title	Publication Date	Language	Citations
Mechanism-based inactivation of human cytochrome P450 enzymes: strategies for diagnosis and drug–drug interaction risk assessment	2007/11/01	English	54
The Metabolism of 3-Chloro-, 3-Bromo- and 3-Iodopropan-1,2-diol in Rats and Mice	1975/01/01	English	54
Differences in the biotransformation of a 17β-hydroxylated steroid, trenbolone acetate, in rat and cow	1981/01/01	English	54
Induction of cytochrome P450 isoenzymes in cultured precision-cut rat and human liver slices	1996/01/01	English	54
Glutathione depletion: Its effects on other antioxidant systems and hepatocellular damage	1991/01/01	English	54
Molecular modelling of CYP1A subfamily members based on an alignment with CYP102: rationalization of CYP1A substrate specificity in terms of active site amino acid residues	1996/01/01	English	54
Pharmacological significance of the species differences in bupropion metabolism	1987/01/01	English	54
Metabolism of nabumetone (BRL 14777) by various species including man	1984/01/01	English	54
Three-dimensional models of human and other mammalian microsomal P450s constructed from an alignment with P450102 (P450bm3)	1995/01/01	English	53
In vivoSuppression of Benzene and Styrene Oxidation by Co-administered Toluene in Rats and Effects of Phenobarbital	1972/01/01	English	53
Pharmacokinetic and Metabolic Studies of the Hypoxic Cell Radiosensitizer Misonidazole	1978/01/01	English	53
A species difference in the presystemic metabolism of carbazeran in dog and man	1984/01/01	English	53
Interindividual and interspecies variation in the metabolism of the hallucinogen 4-methoxyamphetamine	1979/01/01	English	53
Plasma protein binding of ceftriaxone	1987/01/01	English	53
β-Apo-8′-carotenal, but not β-carotene, is a strong inducer of liver cytochromes P4501A1 and 1A2 in rat	1996/01/01	English	53
Cytochrome P-450-dependent formation of reactive oxygen radicals: isozyme-specific inhibition of P-450-mediated reduction of oxygen and carbon tetrachloride	1990/01/01	English	53
Potent and selective inhibition of magnolol on catalytic activities of UGT1A7 and 1A9	2012/05/16	English	53
Studies on the Metabolism of Ethynylestradiolin vitroandin vivo: The Significance of 2-Hydroxylation and the Formation of Polar Products	1973/01/01	English	53
Separation of multiple forms of glutathioneS-transferase from the Blue Mussel,Mytilus edulis	1993/01/01	English	53
A reporter gene assay to assess the molecular mechanisms of xenobiotic-dependent induction of the human CYP3A4 genein vitro	1999/01/01	English	52
The Metabolism of Vanillin and Isovanillin in the Rat	1975/01/01	English	52
Microbial cleavage of zearalenone	1988/01/01	English	52
Functional involvement of organic cation transporter1 (OCT1/Oct1) in the hepatic uptake of organic cations in humans and rats	2007/08/01	English	52
Identification of cytochrome P450 forms involved in the 4-hydroxylation of valsartan, a potent and specific angiotensin II receptor antagonist, in human liver microsomes	2005/06/01	English	51
Method for predicting the risk of drug–drug interactions involving inhibition of intestinal CYP3A4 and P-glycoprotein	2009/06/01	English	51
Human-liver cytochromes P-450 involved in polymorphisms of drug oxidation	1986/01/01	English	51
Metabolism of Chlorodiphenyl Ethers and Irgasan® DP 300	1979/01/01	English	51
Metabolic aspects of antioxidants and preservatives	1986/01/01	English	51
The reduction of sulphinpyrazone and sulindac by intestinal bacteria	1987/01/01	English	51
Terpenoid biotransformation in mammals IV Biotransformation of (+)-longifolene, (-)-caryophyllene, (-)-caryophyllene oxide, (-)-cyclocolorenone, (+)-nootkatone, (-)-elemol, (-)-abietic acid and (+)-dehydroabietic acid in rabbits	1986/01/01	English	50